AdaptHealth Corp. (NASDAQ:AHCO) Holdings Lowered by Royal Bank of Canada

Royal Bank of Canada decreased its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 1.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,891,670 shares of the company's stock after selling 29,677 shares during the period. Royal Bank of Canada owned approximately 1.41% of AdaptHealth worth $18,009,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Barclays PLC lifted its stake in shares of AdaptHealth by 361.3% in the 3rd quarter. Barclays PLC now owns 181,240 shares of the company's stock valued at $2,034,000 after purchasing an additional 141,949 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after buying an additional 1,690 shares during the period. Blue Trust Inc. raised its holdings in AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after buying an additional 1,115 shares during the period. Pacer Advisors Inc. purchased a new stake in AdaptHealth during the fourth quarter worth approximately $76,271,000. Finally, Empowered Funds LLC boosted its position in AdaptHealth by 25.0% during the 4th quarter. Empowered Funds LLC now owns 713,643 shares of the company's stock worth $6,794,000 after purchasing an additional 142,743 shares during the period. Institutional investors and hedge funds own 82.67% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Truist Financial lowered their price objective on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, May 12th. Canaccord Genuity Group lifted their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Robert W. Baird upped their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Royal Bank of Canada decreased their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Finally, UBS Group dropped their target price on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Stock Performance

NASDAQ AHCO traded down $0.14 during trading hours on Friday, hitting $8.85. The company had a trading volume of 135,796 shares, compared to its average volume of 1,281,647. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The firm has a market cap of $1.19 billion, a P/E ratio of -5.38, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The business has a fifty day simple moving average of $8.99 and a 200-day simple moving average of $9.61.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.